• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Perrigo Company plc

    2/13/24 1:05:29 PM ET
    $PRGO
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $PRGO alert in real time by email
    SC 13G 1 prgo13g02132024.htm SCHEDULE 13G






    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    Under the Securities Exchange Act of 1934
    (Amendment No.         )*


    Perrigo Co PLC
    (Name of Issuer)


    Common Stock
    (Title of Class of Securities)


    G97822103
    (CUSIP Number)


    December 31, 2023
    (Date of Event Which Requires Filing of this Statement)


    Check appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☑ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☐ Rule 13d-1(d)


    *
     
    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
     
    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
     

    1


    CUSIP No. G97822103
     
     
     
     
      
      1.
    NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (entities only)
     
    Barrow Hanley Global Investors
    752403190
      2.
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
    (a)  ☐
    (b)  ☐
      3.
    SEC USE ONLY
     
      4.
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    A Delaware limited liability company
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
      5.    SOLE VOTING POWER
     
                  shares
     
      6.    SHARED VOTING POWER
     
                  shares
      7.    SOLE DISPOSITIVE POWER
     
                  shares
      8.    SHARED DISPOSITIVE POWER
     
            —
       9.
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
          shares
    10.
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)
     
    ☐
    11.
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
         %
    12.
    TYPE OF REPORTING PERSON (See Instructions)
     
    IA
     
     
    2

     
    SCHEDULE 13G
     
    Item 1(a)
      
    Name of Issuer: Perrigo Co PLC
       
    1(b)
      
    Address of Issuer’s Principal Executive Offices:
       
     
      
    The Sharp Building, Hogan Place
    Dublin 2, Ireland D02 TY74
       
    Item 2(a)
      
    Name of Person Filing:
         
       
    Barrow Hanley Global Investors
       
    2(b)
      
    Address of Principal Business Office or, if none, Residence:
       
     
      
    2200 Ross Avenue, 31st Floor
    Dallas, TX 75201-2761
       
    2(c)
      
    Citizenship:
       
     
      
    A Delaware limited liability company
     
     
    2(d)
      
    Title of Class of Securities
     
     
     
      
    Common Stock
     
     
    2(e)
      
    CUSIP Number:    G97822103
     
     
    Item 3
      
    If this statement is filed pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:
     
     
     
     
     
      
    (a)
      
    ☐
      
    Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
     
     
     
     
     
      
    (b)
      
    ☐
      
    Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
     
     
     
     
     
      
    (c)
      
    ☐
      
    Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
     
     
     
     
     
      
    (d)
      
    ☐
      
    Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
     
     
     
     
     
      
    (e)
      
    ☑
      
    An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
     
     
     
     
     
      
    (f)
      
    ☐
      
    An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
     
     
     
     
     
      
    (g)
      
    ☐
      
    A parent holding company or control person in accordance with §240.13d-1(b)(ii)(G);
     
     
     
     
     
      
    (h)
      
    ☐
      
    A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
     
     
     
     
     
      
    (i)
      
    ☐
      
    A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
     
     
     
     
     
      
    (j)
      
    ☐
      
    Group, in a accordance with §240.13d-1(b)(1)(ii)(J).
     
     
    3

    Item 4
      
    Ownership:
     
     
     
     
      
    4(a)
      
    Amount beneficially owned:        shares
     
     
     
     
      
    4(b)
      
    Percent of Class:       %
     
     
     
     
      
    4(c)
      
    Number of shares as to which person has:
     
     
      
     
    (i)
    Sole power to vote or to direct the vote:        shares

     
      
    (ii)
    Shared power to vote or to direct the vote:        shares
       
     
      
    (iii)
    Sole power to dispose or to direct the disposition of:        shares
       
     
      
    (iv)
    Shared power to dispose or to direct the disposition of:  —
       
    Item 5
      
    Ownership of Five Percent or Less of a Class:
     
      
     Yes.  
       
    Item 6
      
    Ownership of More than Five Percent on Behalf of Another Person:
     
      
    The right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the common stock is held by certain clients of the reporting person, none of which has such right or power with respect to five percent or more of the common stock.
     
     
    Item 7
      
    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company:
     
      
    Not Applicable.
     
     
    Item 8
      
    Identification and Classification of Members of the Group:
     
      
    Not Applicable.
       
    Item 9
      
    Notice of Dissolution of Group:
     
      
    Not Applicable.
       
    Item 10
      
    Certification:
       
       
    By signing below the undersigned certifies that, to the best of its knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

    After reasonable inquiry and to the best of my knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.

     
    Barrow Hanley Global Investors
           
     
    By:
    /s/ Hannah Ackels
     
       
    Name:  Hannah Ackels
     
       
    Title:   Chief Compliance Officer
     
           
     
     February 13, 2024
    4
    Get the next $PRGO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $PRGO

    DatePrice TargetRatingAnalyst
    1/14/2025Buy → Hold
    Argus
    1/6/2025$34.00 → $27.00Overweight → Neutral
    Piper Sandler
    9/24/2024$50.00 → $30.00Hold
    Jefferies
    11/17/2023$37.00Overweight
    Piper Sandler
    3/7/2023$49.00Buy
    Canaccord Genuity
    9/14/2022$46.00Hold → Buy
    Argus
    9/6/2022$48.00 → $54.00Equal Weight → Overweight
    Wells Fargo
    11/11/2021$59.00 → $55.00Outperform
    Raymond James
    More analyst ratings